Screener
NewAmsterdam Pharma Company NAMS Invested capital
Discontinued — last reported Q2 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from NewAmsterdam Pharma Company’s reported figures.
The source filing: NewAmsterdam Pharma Company’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 7:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333824
FAQ
- What is NewAmsterdam Pharma Company's invested capital?
- NewAmsterdam Pharma Company (NAMS) reported invested capital of $207.35M in Q2 2026.
- How has NewAmsterdam Pharma Company's invested capital changed year-over-year?
- NewAmsterdam Pharma Company's invested capital decreased by 3.5% year-over-year, from $214.96M to $207.35M.
- What is the long-term trend for NewAmsterdam Pharma Company's invested capital?
- Over 3 years (2022 to 2025), NewAmsterdam Pharma Company's invested capital has grown at a 72.8% compound annual growth rate (CAGR), from -$37.54M to $193.63M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about NewAmsterdam Pharma Company's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude